Park Ha Biological Technology Co., Ltd. (BYAH) is up 128.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The biggest apparent catalyst is a June 12, 2026 company announcement of a strategic partnership aimed at building an AI-powered skincare and health ecosystem, which can spark speculative buying in a micro-cap name. The magnitude of the move also looks consistent with momentum trading dynamics (thin float, heavy volume) amplifying a single headline.
Details:
Sources:
Park Ha Biological Technology (press release), Stock Analysis, StockTitan
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$BYAH Hedge Fund Activity
We have seen 1 institutional investors add shares of $BYAH stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC removed 340,600 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $357,630
- CITADEL ADVISORS LLC removed 93,828 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $98,519
- XTX TOPCO LTD removed 74,154 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $77,861
- JANE STREET GROUP, LLC removed 37,215 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $39,075
- GROUND SWELL CAPITAL, LLC removed 20,925 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,327
- GEODE CAPITAL MANAGEMENT, LLC removed 16,854 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $17,696
- STONEX GROUP INC. removed 15,950 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $16,747
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.